Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jun 2;16(6):980-981.
doi: 10.1021/acsmedchemlett.5c00305. eCollection 2025 Jun 12.

Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory Diseases

Ram W Sabnis  1
Affiliations
Editorial

Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory Diseases

Ram W Sabnis. ACS Med Chem Lett. .

Abstract

Provided herein are novel bicyclic heterocycles as MRGPRX2 antagonists, pharmaceutical compositions, use of such compounds in treating inflammatory diseases, and processes for preparing such compounds.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Gour N., Dong X.. The MRGPR family of receptors in immunity. Immunity. 2024;57:28–39. doi: 10.1016/j.immuni.2023.12.012. - DOI - PMC - PubMed
    1. Castells M., Madden M., Oskeritzian C. A.. Mast cells and mas-related G protein-coupled receptor X2: Itching for novel pathophysiological insights to clinical relevance. Curr. Allergy Asthma Rep. 2025;25:5. doi: 10.1007/s11882-024-01183-5. - DOI - PMC - PubMed
    1. Guth C., Limjunyawong N., Pundir P.. The evolving role of mast cells in wound healing: insights from recent research and diverse models. Immunol. Cell Biol. 2024;102:878–890. doi: 10.1111/imcb.12824. - DOI - PubMed
    1. Van Remoortel S., Hussein H., Boeckxstaens G.. Mast cell modulation: A novel therapeutic strategy for abdominal pain in irritable bowel syndrome. Cell Rep. Med. 2024;5:101780. doi: 10.1016/j.xcrm.2024.101780. - DOI - PMC - PubMed
    1. Sabnis R. W.. Novel bicyclic heterocycles as MRGPRX2 antagonists for treating inflammatory diseases. ACS Med. Chem. Lett. 2025;16:732–733. doi: 10.1021/acsmedchemlett.5c00165. - DOI - PMC - PubMed

Publication types

LinkOut - more resources